Effect of adjuvant trastuzumab among patients treated with anti-HER2-based neoadjuvant therapy

PURPOSE: To study the impact of adjuvant trastuzumab among patients achieving a pathologic complete response (pCR) after trastuzumab-based neoadjuvant systemic therapy (NST). PATIENTS AND METHODS: Patients with primary HER2-positive breast cancer treated with trastuzumab-based NST were categorised a...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Br J Cancer
Prif Awduron: Gonzalez-Angulo, A M, Parinyanitikul, N, Lei, X, Mittendorf, E A, Zhang, H, Valero, V, Hunt, K K, Hortobagyi, G N, Chavez-MacGregor, M
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Nature Publishing Group 2015
Pynciau:
Clinical Study
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4333494/
https://ncbi.nlm.nih.gov/pubmed/25584488
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.647
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg